You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 11, November 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  Vignettes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acute Neutrophilic Dermatosis Associated With Hydralazine-Induced Lupus

O. Servitje, MD; M. Ribera, MD; X. Juanola, MD; J. Rodriguez-Moreno, MD
Dermatology Service; Rheumatology Service Department of Medicine Hospital de Bellvitage "Princeps d'Espanya" L'Hospitalet de Llobregat Barcelona, Spain

Arch Dermatol. 1987;123(11):1435-1436.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Acute febrile neutrophilic dermatosis (Sweet's syndrome) has been reported in association with many medical disorders and, especially, with myeloid and myelomonocytic leukemia.1 As far as the connective tissue disorders are concerned, this dermatosis has only been reported in a case of Sjögren's syndrome2 and, recently, in a patient with subacute lupus erythematosus.3 We report a case of a patient with hydralazine-induced lupus who simultaneously developed Sweet's syndrome. To our knowledge, only one previous case of this association is reported in the medical literature.4

Report of a Case.—

A 68-year-old man with a history of essential hypertension received hydralazine over a period of nine years at a daily dose of 200 mg. In 1985 he developed an acute eruption of painful cutaneous lesions and fever. During the previous seven months he suffered from asthenia, anorexia, arthralgia, and a 10-kg weight loss . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.